These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 25318803)
1. Pulmonary arterial hypertension as the first manifestation in a patient with hereditary hemorrhagic telangiectasia. Ishiwata T; Terada J; Tanabe N; Abe M; Sugiura T; Tsushima K; Tada Y; Sakao S; Kasahara Y; Nakanishi N; Morisaki H; Tatsumi K Intern Med; 2014; 53(20):2359-63. PubMed ID: 25318803 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia Related to an ACVRL1 Mutation. Yokokawa T; Sugimoto K; Kimishima Y; Misaka T; Yoshihisa A; Morisaki H; Yamada O; Nakazato K; Ishida T; Takeishi Y Intern Med; 2020 Jan; 59(2):221-227. PubMed ID: 31511490 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report. Walsh LJ; Collins C; Ibrahim H; Kerins DM; Brady AP; O Connor TM J Med Case Rep; 2022 Mar; 16(1):99. PubMed ID: 35232468 [TBL] [Abstract][Full Text] [Related]
4. ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension. Eyries M; Coulet F; Girerd B; Montani D; Humbert M; Lacombe P; Chinet T; Gouya L; Roume J; Axford MM; Pearson CE; Soubrier F Clin Genet; 2012 Aug; 82(2):173-9. PubMed ID: 21651515 [TBL] [Abstract][Full Text] [Related]
5. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia. Smoot LB; Obler D; McElhinney DB; Boardman K; Wu BL; Lip V; Mullen MP Arch Dis Child; 2009 Jul; 94(7):506-11. PubMed ID: 19357124 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary arterial hypertension and portal hypertension in a patient with hereditary hemorrhagic telangiectasia. Pousada G; Baloira A; Valverde D Med Clin (Barc); 2015 Mar; 144(6):261-4. PubMed ID: 25543221 [TBL] [Abstract][Full Text] [Related]
7. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype. Bossler AD; Richards J; George C; Godmilow L; Ganguly A Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392 [TBL] [Abstract][Full Text] [Related]
8. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia. Rigelsky CM; Jennings C; Lehtonen R; Minai OA; Eng C; Aldred MA Am J Med Genet A; 2008 Oct; 146A(19):2551-6. PubMed ID: 18792970 [TBL] [Abstract][Full Text] [Related]
9. Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2. Du J; Zhu Y; Zhang YL; Li S; Huang J; Luo XH; Liu L J Thromb Thrombolysis; 2015 Nov; 40(4):515-9. PubMed ID: 26245826 [TBL] [Abstract][Full Text] [Related]
10. Curaçao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2). McDonald J; Bayrak-Toydemir P; DeMille D; Wooderchak-Donahue W; Whitehead K Genet Med; 2020 Jul; 22(7):1201-1205. PubMed ID: 32300199 [TBL] [Abstract][Full Text] [Related]
11. [Clinical features and screening of ACVRL1 gene in II hereditary hemorrhagic telangiectasia]. Jia JJ; Zhang J; Zhao LD; Zhou XJ; Cheng J; Yuan HJ; Wang HT Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1107-11. PubMed ID: 22781769 [TBL] [Abstract][Full Text] [Related]
12. [Gene diagnosis and treatment of hereditary hemorrhagic telangiectasia with epistaxis as its main symptom]. Leng H; Zhang Q; Shi L Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):591-592. PubMed ID: 31327192 [No Abstract] [Full Text] [Related]
13. [Hereditary pulmonary hypertension family with Lin YK; Yang DH; Lei C; Luo H Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jun; 46(6):558-564. PubMed ID: 37278169 [No Abstract] [Full Text] [Related]
14. [Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)]. Major T; Gindele R; Szabó Z; Jóni N; Kis Z; Bora L; Bárdossy P; Rácz T; Karosi T; Bereczky Z Orv Hetil; 2019 May; 160(18):710-719. PubMed ID: 31030535 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterio-venous malformations in a patient with a novel mutation in exon 10 of the ACVRL1 gene. Vandenbriele C; Peerlinck K; de Ravel T; Verhamme P; Vanassche T Acta Clin Belg; 2014 Apr; 69(2):139-41. PubMed ID: 24724759 [TBL] [Abstract][Full Text] [Related]
17. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1. Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827 [TBL] [Abstract][Full Text] [Related]
18. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia. Brakensiek K; Frye-Boukhriss H; Mälzer M; Abramowicz M; Bahr MJ; von Beckerath N; Bergmann C; Caselitz M; Holinski-Feder E; Muschke P; Oexle K; Strobl-Wildemann G; Wolff G; El-Harith EA; Stuhrmann M Clin Genet; 2008 Aug; 74(2):171-7. PubMed ID: 18498373 [TBL] [Abstract][Full Text] [Related]
19. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital. Karlsson T; Cherif H Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589 [TBL] [Abstract][Full Text] [Related]
20. The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure. Ayala E; Kudelko KT; Haddad F; Zamanian RT; de Jesus Perez V Chest; 2012 Jun; 141(6):1598-1600. PubMed ID: 22670022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]